news and events
ClinDatrix provided full service for the successful Phase 3 study of the following contact lens solution for Bausch + Lomb:
Bausch + Lomb Introduces renu® Advanced Formula Multi-Purpose Solution
ClinDatrix provided full service for the Phase 2 and Phase 3 studies leading to the approval of Endari, an orphan drug for sickle cell disease for Emmaus Medical:
FDA approves new treatment for sickle cell disease
We look forward to meeting with you in person – at your office or ours, or at an upcoming industry conference.
Events
| Sep 27-28, 2017 | Outsourcing in Clinical Trials Southern California, La Jolla, CA |
| Oct 25-26, 2017 | Outsourcing in Clinical Trials Pacific Northwest, Seattle, WA |
| Jun 24-28, 2018 | DIA, Boston, MA |
| Sep 12-13, 2018 | Outsourcing in Clinical Trials Midwest, Chicago, IL |
| Sep 26-27, 2018 | Outsourcing in Clinical Trials Southern California, La Jolla, CA |
| Feb 21-22, 2018 | Outsourcing in Clinical Trials West Coast, Burlingame, CA |
| Oct 23-24, 2018 | Outsourcing in Clinical Trials Canada, Vancouver BC |